Goldman Sachs
BPTH

Goldman Sachs’s Bio-Path Holdings Inc BPTH Stock Holding History

Goldman Sachs’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-840
Closed -$59K – 6422
2020
Q4 		$59K Buy
+840
New +$63K ﹤0.01% 5360
2018
Q2 		– Sell
-28
Closed -$23K – 6106
2018
Q1 		$23K Buy
28
+25
+833% +$19.5K ﹤0.01% 5653
2017
Q4 		$2K Hold
3
– – ﹤0.01% 6283
2017
Q3 		$4K Sell
3
-4
-57% -$5.49K ﹤0.01% 6587
2017
Q2 		$11K Buy
7
+3
+75% +$6.29K ﹤0.01% 6644
2017
Q1 		$13K Hold
4
– – ﹤0.01% 6587
2016
Q4 		$19K Sell
4
-3
-43% -$14.5K ﹤0.01% 6661
2016
Q3 		$38K Buy
7
+2
+40% +$12.8K ﹤0.01% 6564
2016
Q2 		$38K Sell
5
-45
-90% -$456K ﹤0.01% 6512
2016
Q1 		$519K Buy
50
+1
+2% +$6.48K ﹤0.01% 4704
2015
Q4 		$244K Sell
49
-12
-20% -$70K ﹤0.01% 5539
2015
Q3 		$280K Sell
61
-1
-2% -$4.69K ﹤0.01% 5681
2015
Q2 		$284K Buy
62
+55
+786% +$301K ﹤0.01% 5792
2015
Q1 		$49K Sell
7
-7
-50% -$58.9K ﹤0.01% 6696
2014
Q4 		$148K Sell
14
-3
-18% -$31K ﹤0.01% 6369
2014
Q3 		$134K Sell
17
-26
-60% -$251K ﹤0.01% 6431
2014
Q2 		$522K Buy
43
+25
+139% +$274K ﹤0.01% 5275
2014
Q1 		$186K Buy
+18
New +$225K ﹤0.01% 6131

Other funds holding BPTH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HI
Human Investing Lake Oswego, Oregon $771M AUM 18.84% 1-Year Est. Return

Goldman Sachs's BPTH Position: Q1 2021 in Review

Goldman Sachs sold out of Bio-Path Holdings Inc (BPTH) in Q1 2021, closing a stake of 840 shares — an estimated $59K sold.

Goldman Sachs first reported a position in BPTH in Q1 2014 and held it in 18 quarters. The position peaked at $522K in Q2 2014. 19 funds tracked by Wall St. Rank hold BPTH as of Q1 2021.

  • Goldman Sachs reported no remaining Bio-Path Holdings Inc position as of Q1 2021 after selling out during the quarter.
  • Goldman Sachs sold 840 Bio-Path Holdings Inc shares in Q1 2021, an estimated $59K.
  • Goldman Sachs first reported a position in Bio-Path Holdings Inc in Q1 2014 and held it in 18 quarters.
  • Goldman Sachs's Bio-Path Holdings Inc position peaked at $522K in Q2 2014.
  • 19 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q1 2021.

Based on Goldman Sachs's 13F filing for Q1 2021, filed 17 May 2021.